Michael R. Jorgensen

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.

IBOD Imaging, Inc. is a development stage medical imaging company working to create a new means for the improved diagnosis of malignant breast disease through the identification of abnormal vascularization associated with tumors. The Company's first application of the technology is the ComfortScan® system, which is a gentle, non-invasive, and non-ionizing optical imaging system designed to assist physicians in the identification and management of breast cancer as an adjunct to screening mammography. IBOD Imaging was founded on september 7, 1999 and is headquartered in Paramus, NJ.